Stony Brook University opens new center to treat valvular heart disease

Stony Brook University Medical Center has opened a new Valve Center that offers comprehensive treatment of valvular heart disease.

Valvular heart disease is any disease process involving one or more of the valves of the heart. According to the American Heart Association, a person can be born with an abnormal heart valve, or a valve can become damaged by infections such as endocarditis, rheumatic fever or changes in valve structure in the elderly. Treatment options include medication or, depending on the severity, valve repair or replacement by inserting an artificial heart valve.

The Valve Center is located within the Stony Brook University Heart Center, off the main lobby of the Hospital. It provides a multi-disciplinary approach to treatment of valve disease, in which the cardiologist and cardiothoracic surgeon provide a comprehensive diagnostic assessment and the best therapeutic option tailored to the patient's specific valve disease. A nurse practitioner also meets with each patient to coordinate evaluation and treatment.

"The goal of the Valve Center is to provide patients with a thorough diagnostic evaluation of their valve disease, so they have a better understanding of their condition. We provide them with a detailed plan of their treatment in a language they can understand and trust," said Smadar Kort, M.D., FACC, FASE, Professor of Medicine at Stony Brook University School of Medicine and Director of the Valve Center Dr. Kort has board certifications in cardiovascular disease and echocardiology and is nationally and internationally known for her expertise in the field of echocardiography.

Another goal of the center is to improve the time from initial patient referral to diagnosis to treatment. Patients referred to the Valve Center will be seen within one week of referral. The time from diagnosis to treatment will be reduced by coordinating all tests and consultations into a single patient visit whenever possible.

The Valve Center will provide a comprehensive range of diagnostic and treatment options for our patients," said Sandeep Gupta, M.D., Assistant Professor of Surgery in Stony Brook University School of Medicine's Division of Cardiothoracic Surgery, who serves as Co-Director of the Valve Center. "It capitalizes upon the longstanding experience and expertise of a team that has collectively performed more than 15,000 heart operations."

Diagnostic services at the Valve Center include the Echocardiography Laboratory, which provides more than 13,000 imaging studies annually and is the only laboratory in Suffolk County with triple accreditation from the Intersocietal Accreditation Commission. Diagnostic studies performed on site include 3D TTE (transthoracic echocardiogram), 3D TEE (transesophageal echocardiogram) and stress echocardiography.

Treatment options include genetic and nutritional counseling, medical therapy and a full spectrum of surgical therapy, including mitral valve repair and aortic valve-sparing procedures for appropriate candidates.

Specialists at the Stony Brook University Heart Center will collaborate and communicate closely with the patient's personal cardiologist and primary care physician in determining the treatment plan. When appropriate, patients may be referred to other services at the Heart Center, such as the 320-slice CT scanner and Electrophysiology program.

Through a collaboration with New York Presbyterian Hospital/Columbia University Medical Center, Stony Brook University Heart Center will also screen and refer patients for less invasive percutaneous therapeutic treatment options that are available only in selected centers nationwide.

Source: Stony Brook University Heart Center:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
CRISPR-based therapy shown to be safe, effective for people with transthyretin amyloidosis